Validation and Performance of Quantitative BRCA1 and RAD51C Promoter Hypermethylation Testing in Breast and Ovarian Cancers
Publication Source: The Journal of Molecular Diagnostics
TBC
Utilizing Pillar Biosciences’ Rapid oncoReveal 4-Gene Methylation Panel to Guide PARPi Therapy in Breast Cancer Patients
Event Name: AMP 2024
TBC
Looking Deeper into HRD to Inform PARP Inhibitor Therapy: Building the Case for NGS Methylation Testing
Publishing Entity: GenomeWeb | Precision Medicine Online
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for BRCA Methylation Testing?
Publication Source: American Society of Clinical Oncology
TBC